Key result
Preoperative estimated pulmonary arterial systolic pressure ≥47 mm Hg was associated with an increased risk of postoperative MACEs.
Why the study?
Pulmonary hypertension increases postoperative risk, but the relation between preoperative ePASP and postoperative cardiac outcomes, as well as a clinically meaningful ePASP threshold in postcapillary pulmonary hypertensive patients, required evaluation.
Does a preoperative ePASP ≥47 mm Hg increase the risk of postoperative MACEs in postcapillary pulmonary hypertensive patients undergoing elective noncardiac surgery?
Cohort (n=16,210)
No
Does a preoperative ePASP ≥47 mm Hg increase the risk of postoperative MACEs in postcapillary pulmonary hypertensive patients undergoing elective noncardiac surgery?
A preoperative echocardiographic estimated pulmonary arterial systolic pressure ≥47 mm Hg is an independent predictor of postoperative MACEs in patients with postcapillary pulmonary hypertension undergoing noncardiac surgery.
Answers are grounded in this paper and cite their sources.
ePASP elevation was associated with higher MACE risk; leaves open whether thresholds should guide perioperative management in postcapillary PH.
Pulmonary hypertension is associated with increased postoperative risk. This study analyzed the relation between the preoperative echocardiographic estimated blood pressure (estimated pulmonary arterial systolic pressure [ePASP]) of noncardiac patients and postoperative cardiac outcome and tried to identify a clinically meaningful threshold for ePASP in postcapillary pulmonary hypertensive patients. This was a single-center retrospective cohort study with propensity score analysis based on patients who underwent elective noncardiac surgery from June 2012 to December 31, 2018. We evaluated the relation between ePASP and the development of postoperative major adverse cardiac events (MACEs). Multivariate logistic regression models and generalized additive models were used, and the minimum p value approach was used to identify the threshold of ePASP that independently indicated the risk of MACEs. Finally, propensity score matching was used for patients with ePASP above or below the threshold, and the exposure effect was evaluated. Of the 16,210 surgeries, 7.0% experienced postoperative MACEs. The threshold for the ePASP was 47 mm Hg. Adjusted odds ratios for MACEs before and after propensity score matching were 2.03 (1.22 to 2.83) and 1.62 (1.01 to 2.23), respectively. In conclusion, the incidence of postoperative MACEs was 7.0% in patients who underwent elective noncardiac surgery. An ePASP ≥47 mm Hg was significantly associated with an increased risk of postoperative MACEs in postcapillary pulmonary hypertensive patients.
No takes yet. Share an insight, caveat, or question.
A 2022 study conducted a cohort in Postcapillary pulmonary hypertension undergoing noncardiac surgery (n=16,210). Preoperative ePASP ≥47 mm Hg vs. Preoperative ePASP <47 mm Hg was evaluated on Postoperative major adverse cardiac events (MACEs) (OR 1.62, 95% CI 1.01-2.23). Preoperative estimated pulmonary arterial systolic pressure ≥47 mm Hg was associated with an increased risk of postoperative MACEs.
Synapse has enriched 10 related papers. Consider them for comparative context: